• AIDS in Africa — Global Issues
  • HIV/AIDS - Wikipedia
  • HIV - Wikipedia

"On average, 91% of the sequences were not significantly similar to those in the extant databases." Xiaoyun Qiu, Aditi U.

Division of Global Migration and Quarantine | CDC

AIDS in Nigeria | AIDS in Nigeria Wiki | FANDOM …

AIDS is man-made - Interview with Dr. Boyd Graves
In 1932, the infectious agent of HIV was first tested on sheep in Iceland. That agent is called Visna. In 1932, in conjunction with the Tuskegee syphilis program, they were testing the infectious agent of HIV on an island nation. We have Visna as 30 percent of the sequences of the HIV here today. So, 1932 not only is significant for the start of a push for eugenics, i.e. a White birth order, but also the start of the testing of the infectious agent of HIV in AIDS.

Boy's 1969 death suggests AIDS invaded U.S. several times

Some believed, erroneously, that you could catch Aids from a coffee cup or a lavatory seat, or by shaking hands with an infected person. When Princess Diana shook hands publicly with an AIDS victim in 1989 it was seen of huge significance. For a long time, too, it was believed that anal sex was key to transmission of the human immunodeficiency virus (HIV). That was not the case. No one then imagined that one of the surest routes of HIV infection would prove to be from a pregnant woman to her child during birth.


28/10/1987 · LEAD: New evidence that a St

HIV, an RNA retro virus, has been photographed, its genome sequenced and the mechanism by which it cripples, then destroys the immune system (by attacking CD4 T-cells) elucidated in the minutest detail. We also know that HIV emerged (probably) in the central African jungles in the early 20th century and became a global pandemic in the 1980s. Carriers can remain ignorant of their infection and healthy for years – greatly increasing the chance of transmission – before Aids develops. There is still no cure or vaccine but, provided you are lucky enough to live in a place where the new combinations of antiretroviral drugs (the buzz-term is HAART, highly-active antiretroviral therapy) are available and your health system can afford to pay for them, being HIV-positive is no longer a death sentence.

The Global 2000 plan is a hideous plan that magnifies the Hitler/Jewish Holocaust by about 50 percent with respect to the number of people that have been planned for extermination. Much of that is the Global 2000 plan and the King Alfred Plan. But it was also drawn up in the U.S. Public Law 91-213 that was signed on March 16, 1970 by President Richard Nixon which, in essence, authorizes HIV/AIDS and the development of HIV/AIDS as a matter of Public Law of the United States of America.

Global Outreach | Focus on the Family

* Oral Polio Vaccine (OPV) is safe and effective and the recommended vaccine for the global effort to eradicate polio and certify the world polio-free by 2005. It is the only vaccine proven to stop transmission of the virus in developing countries. Using this vaccine, the global campaign to eradicate polio has achieved a more than 95 per cent decrease in the number of polio cases world-wide in the twelve years since it was launched, and is on track to eradicate the disease.

National AIDS Treatment Advocacy Project - HCV …

To estimate the value of the microneutralization titer corresponding to a hemagglutination titer of 40 (a measure that has been associated with at least a 50% reduction in the risk of infection or disease with influenza viruses in human populations), we performed a correlation analysis using linear regression models. Analyses were performed to fit linear regression and multivariable models, to perform t-tests, and to estimate geometric mean titers (GMTs) with confidence intervals and corresponding P values with the use of SAS software (version 9.1). For analysis of the data for the 417 serum samples, we evaluated titers on the basis of the birth decade of the serum donor and computed the cumulative GMT by averaging the mean log microneutralization titers for that specific decade and preceding decades, giving each decade equal weight regardless of varying sample sizes. A P value of less than 0.05 was considered to indicate statistical significance. (For details regarding the statistical analysis, see the .)


Vaccination of 344 adults with inactivated seasonal vaccine resulted in seroconversion against the seasonal H1N1 vaccine strain in 65 of 83 adults between the ages of 18 and 40 years (78%), in 111 of 148 of those between the ages of 18 and 64 years (75%), and in 9 of 49 (18%) and 34 of 63 (54%) of those 60 years of age or older, depending on the year (). Seroconversion to antibodies against 2009 H1N1 was observed in 10 of 83 adults (12%) between the ages of 18 and 40 years, in 33 of 148 adults (22%) between the ages of 18 and 64 years, and in 3 of 63 (5%) or none of 50 adults 60 years of age or older, depending on the year. The ratios between the GMT after vaccination to the GMT before vaccination for the response to 2009 H1N1 ranged from 1 to 2 in both the adult and older-adult age groups, as compared with the GMT ratios observed for the seasonal H1N1 vaccine component ranging from 2 to 19 (Table 3 in the ). However, 6 to 7% of 231 adults and up to one third of 113 older adults had prevaccination microneutralization antibody titers of 160 or more against 2009 H1N1. Vaccination with the 2007–2008 seasonal vaccine, but not with the 2008–2009 seasonal vaccine, resulted in a modest boost in the cross-reactive antibody response, which was probably driven by the higher prevaccination GMTs detected in 2007–2008 samples, as compared with 2008–2009 samples. Interestingly, the prevaccination antibody GMT of older adults against 2009 H1N1 was significantly higher than the GMT in the seasonal 2007–2008 H1N1 vaccine component (P).